Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, Maj-Linda B., Brownlow, Milene, Jimenez, Jeffy P., Lee, Daniel C., Pena, Gabriela, Dickey, Chad A., Gordon, Marcia N., Morgan, Dave·2013·Neurodegenerative Diseases

Cited by (1,606)

Items 1,301–1,400 of 1,606

  1. Changes in the detergent‐insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression
    Hales, Chadwick M., Dammer, Eric B., Deng, Qiudong, Duong, Duc M., Gearing, Marla, Troncoso, Juan C., Thambisetty, Madhav, Lah, James J., Shulman, Joshua M., Levey, Allan I. et al. · 2016 · PROTEOMICS
  2. G-protein coupled receptor, PI3K and Rho signaling pathways regulate the cascades of Tau and amyloid-β in Alzheimer’s disease
    Desale, Smita Eknath, Chidambaram, Hariharakrishnan, Chinnathambi, Subashchandrabose · 2021 · Molecular Biomedicine
  3. Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer’s disease pathology
    Ahnaou, A., Moechars, D., Raeymaekers, L., Biermans, R., Manyakov, N. V., Bottelbergs, A., Wintmolders, C., Van Kolen, K., Van De Casteele, T., Kemp, J. A. et al. · 2017 · Scientific Reports
  4. Heat Shock Protein Inspired Nanochaperones Restore Amyloid-β Homeostasis for Preventative Therapy of Alzheimer’s Disease
    Yang, Huiru, Li, Xinyu, Zhu, Lin, Wu, Xiaohui, Zhang, Shaozhi, Huang, Fan, Feng, Xizeng, Shi, Linqi · 2019 · Advanced Science
  5. Activated forms of astrocytes with higher GLT-1 expression are associated with cognitive normal subjects with Alzheimer pathology in human brain
    Kobayashi, Eiji, Nakano, Masako, Kubota, Kenta, Himuro, Nobuaki, Mizoguchi, Shougo, Chikenji, Takako, Otani, Miho, Mizue, Yuka, Nagaishi, Kanna, Fujimiya, Mineko · 2018 · Scientific Reports
  6. Brain-specific repression of AMPKα1 alleviates pathophysiology in Alzheimer’s model mice
    Zimmermann, Helena R., Yang, Wenzhong, Kasica, Nicole P., Zhou, Xueyan, Wang, Xin, Beckelman, Brenna C., Lee, Jingyun, Furdui, Cristina M., Keene, C. Dirk, Ma, Tao · 2020 · Journal of Clinical Investigation
  7. Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
    Mroczko, Barbara, Groblewska, Magdalena, Litman-Zawadzka, Ala, Kornhuber, Johannes, Lewczuk, Piotr · 2018 · International Journal of Molecular Sciences
  8. Tau phosphorylation regulates the interaction between BIN1’s SH3 domain and Tau’s proline-rich domain
    Sottejeau, Yoann, Bretteville, Alexis, Cantrelle, François-Xavier, Malmanche, Nicolas, Demiaute, Florie, Mendes, Tiago, Delay, Charlotte, Alves Dos Alves, Harmony, Flaig, Amandine, Davies, Peter et al. · 2015 · Acta Neuropathologica Communications
  9. Sequential formation of different layers of dystrophic neurites in Alzheimer’s brains
    Sharoar, Md Golam, Hu, Xiangyou, Ma, Xin-Ming, Zhu, Xiongwei, Yan, Riqiang · 2019 · Molecular Psychiatry
  10. Targeting tau: clinical trials and novel therapeutic approaches
    VandeVrede, Lawren, Boxer, Adam L., Polydoro, Manuela · 2020 · Neuroscience Letters
  11. Molecular and functional signatures in a novel Alzheimer’s disease mouse model assessed by quantitative proteomics
    Kim, Dong Kyu, Park, Joonho, Han, Dohyun, Yang, Jinhee, Kim, Ahbin, Woo, Jongmin, Kim, Youngsoo, Mook-Jung, Inhee · 2018 · Molecular Neurodegeneration
  12. Cromolyn Reduces Levels of the Alzheimer’s Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis
    Zhang, Can, Griciuc, Ana, Hudry, Eloise, Wan, Yu, Quinti, Luisa, Ward, Joseph, Forte, Angela M., Shen, Xunuo, Ran, ChongZhao, Elmaleh, David R. et al. · 2018 · Scientific Reports
  13. Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes
    Gómez-Isla, Teresa, Frosch, Matthew P. · 2022 · Nature Reviews Neurology
  14. Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies
    Dominantly Inherited Alzheimer Network, Ringman, John M., Goate, Alison, Masters, Colin L., Cairns, Nigel J., Danek, Adrian, Graff-Radford, Neill, Ghetti, Bernardino, Morris, John C. · 2014 · Current Neurology and Neuroscience Reports
  15. CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer’s Disease
    Shentu, Yang-Ping, Huo, Yuda, Feng, Xiao-Long, Gilbert, James, Zhang, Qing, Liuyang, Zhen-Yu, Wang, Xiu-Lian, Wang, Guan, Zhou, Huan, Wang, Xiao-Chuan et al. · 2018 · Cell Reports
  16. Current Status of Clinical Trials on Tau Immunotherapies
    Ji, Changyi, Sigurdsson, Einar M. · 2021 · Drugs
  17. Amyloid-β Oligomers May Impair SNARE-Mediated Exocytosis by Direct Binding to Syntaxin 1a
    Yang, Yoosoo, Kim, Jaewook, Kim, Hye Yun, Ryoo, Nayeon, Lee, Sejin, Kim, YoungSoo, Rhim, Hyewhon, Shin, Yeon-Kyun · 2015 · Cell Reports
  18. Alzheimer's disease pathology in the neocortex and hippocampus of the western lowland gorilla (<i>Gorilla gorilla gorilla</i>)
    Perez, Sylvia E., Raghanti, Mary Ann, Hof, Patrick R., Kramer, Lynn, Ikonomovic, Milos D., Lacor, Pascale N., Erwin, Joseph M., Sherwood, Chet C., Mufson, Elliott J. · 2013 · Journal of Comparative Neurology
  19. Amyloid plaque structure and cell surface interactions of β-amyloid fibrils revealed by electron tomography
    Han, Shen, Kollmer, Marius, Markx, Daniel, Claus, Stephanie, Walther, Paul, Fändrich, Marcus · 2017 · Scientific Reports
  20. Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrP<sup>Sc</sup>, even upon LPS stimulation
    Hughes, Martina M., Field, Robert H., Perry, V. Hugh, Murray, Carol L., Cunningham, Colm · 2010 · Glia
  21. Genetics of age-related macular degeneration: current concepts, future directions
    DeAngelis, Margaret M., Silveira, Alexandra C., Carr, Elizabeth A., Kim, Ivana K. · 2011 · Seminars in Ophthalmology
  22. Lipoprotein Lipase Is a Feature of Alternatively-Activated Microglia and May Facilitate Lipid Uptake in the CNS During Demyelination
    Bruce, Kimberley D., Gorkhali, Sachi, Given, Katherine, Coates, Alison M., Boyle, Kristen E., Macklin, Wendy B., Eckel, Robert H. · 2018 · Frontiers in Molecular Neuroscience
  23. Neuroimaging in Dementia
    Staffaroni, Adam, Elahi, Fanny, McDermott, Dana, Marton, Kacey, Karageorgiou, Elissaios, Sacco, Simone, Paoletti, Matteo, Caverzasi, Eduardo, Hess, Christopher, Rosen, Howard et al. · 2017 · Seminars in Neurology
  24. Physiological Roles of Amyloid-?? and Implications for its Removal in Alzheimer???s Disease
    Bishop, Glenda M, Robinson, Stephen R · 2004 · Drugs &amp; Aging
  25. Tau-directed drug discovery for alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors
    Brunden, Kurt R., Ballatore, Carlo, Crowe, Alex, Smith,, Amos B., Lee, Virginia M.-Y., Trojanowski, John Q. · 2010 · Experimental Neurology
  26. The Deacetylase HDAC6 Mediates Endogenous Neuritic Tau Pathology
    Tseng, Jui-Heng, Xie, Ling, Song, Sheng, Xie, Youmei, Allen, Lauren, Ajit, Deepa, Hong, Jau-Shyong, Chen, Xian, Meeker, Rick B., Cohen, Todd J. · 2017 · Cell Reports
  27. In vivo imaging of tau pathology using multi-parametric quantitative MRI
    Wells, J.A., O'Callaghan, J.M., Holmes, H.E., Powell, N.M., Johnson, R.A., Siow, B., Torrealdea, F., Ismail, O., Walker-Samuel, S., Golay, X. et al. · 2015 · NeuroImage
  28. Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy
    Chornenkyy, Yevgen, Fardo, David W., Nelson, Peter T. · 2019 · Laboratory Investigation
  29. Proteopathic tau primes and activates interleukin-1β via myeloid-cell-specific MyD88- and NLRP3-ASC-inflammasome pathway
    Jiang, Shanya, Maphis, Nicole M., Binder, Jessica, Chisholm, Devon, Weston, Lea, Duran, Walter, Peterson, Crina, Zimmerman, Amber, Mandell, Michael A., Jett, Stephen D. et al. · 2021 · Cell Reports
  30. Axonal transport of APP and the spatial regulation of APP cleavage and function in neuronal cells
    Brunholz, Silke, Sisodia, Sangram, Lorenzo, Alfredo, Deyts, Carole, Kins, Stefan, Morfini, Gerardo · 2012 · Experimental Brain Research
  31. Deciphering Resting Microglial Morphology and Process Motility from a Synaptic Prospect
    Hristovska, Ines, Pascual, Olivier · 2016 · Frontiers in Integrative Neuroscience
  32. Physiological changes in neurodegeneration—mechanistic insights and clinical utility
    Ahmed, Rebekah M., Ke, Yazi D., Vucic, Steve, Ittner, Lars M., Seeley, William, Hodges, John R., Piguet, Olivier, Halliday, Glenda, Kiernan, Matthew C. · 2018 · Nature Reviews Neurology
  33. Loss of tau rescues inflammation-mediated neurodegeneration
    Maphis, Nicole, Xu, Guixiang, Kokiko-Cochran, Olga N., Cardona, Astrid E., Ransohoff, Richard M., Lamb, Bruce T., Bhaskar, Kiran · 2015 · Frontiers in Neuroscience
  34. Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies
    Buccellato, Francesca R., D’Anca, Marianna, Tartaglia, Gianluca Martino, Del Fabbro, Massimo, Scarpini, Elio, Galimberti, Daniela · 2023 · International Journal of Molecular Sciences
  35. Abundant Aβ fibrils in ultracentrifugal supernatants of aqueous extracts from Alzheimer’s disease brains
    Stern, Andrew M., Yang, Yang, Jin, Shanxue, Yamashita, Keitaro, Meunier, Angela L., Liu, Wen, Cai, Yuqi, Ericsson, Maria, Liu, Lei, Goedert, Michel et al. · 2023 · Neuron
  36. mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementia
    Di Domenico, Fabio, Tramutola, Antonella, Foppoli, Cesira, Head, Elizabeth, Perluigi, Marzia, Butterfield, D. Allan · 2018 · Free Radical Biology and Medicine
  37. The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics
    Pritchard, Susanne M., Dolan, Philip J., Vitkus, Alisa, Johnson, Gail V.W. · 2011 · Journal of Cellular and Molecular Medicine
  38. Haplotype-specific expression of the N-terminal exons 2 and 3 at the human MAPT locus
    Caffrey, Tara M., Joachim, Catharine, Wade-Martins, Richard · 2008 · Neurobiology of Aging
  39. Sex Differences in Risk and Resilience: Stress Effects on the Neural Substrates of Emotion and Motivation
    Wellman, Cara L., Bangasser, Debra A., Bollinger, Justin L., Coutellier, Laurence, Logrip, Marian L., Moench, Kelly M., Urban, Kimberly R. · 2018 · The Journal of Neuroscience
  40. A potential role for alterations of zinc and zinc transport proteins in the progression of Alzheimer's disease
    Lovell, Mark A. · 2009 · Journal of Alzheimer s Disease
  41. Acute and chronically increased immunoreactivity to phosphorylation-independent but not pathological TDP-43 after a single traumatic brain injury in humans
    Johnson, Victoria E., Stewart, William, Trojanowski, John Q., Smith, Douglas H. · 2011 · Acta Neuropathologica
  42. Ten Years of Tau-Targeted Immunotherapy: The Path Walked and the Roads Ahead
    Novak, Petr, Kontsekova, Eva, Zilka, Norbert, Novak, Michal · 2018 · Frontiers in Neuroscience
  43. Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life
    Uhlmann, Ruth E., Rother, Christine, Rasmussen, Jay, Schelle, Juliane, Bergmann, Carina, Ullrich Gavilanes, Emily M., Fritschi, Sarah K., Buehler, Anika, Baumann, Frank, Skodras, Angelos et al. · 2020 · Nature Neuroscience
  44. Characteristics of frontotemporal dementia patients with a <i>Progranulin</i> mutation
    Huey, Edward D., Grafman, Jordan, Wassermann, Eric M., Pietrini, Pietro, Tierney, Michael C., Ghetti, Bernardino, Spina, Salvatore, Baker, Matt, Hutton, Mike, Elder, Joshua W. et al. · 2006 · Annals of Neurology
  45. Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model
    Cook, Casey, Kang, Silvia S., Carlomagno, Yari, Lin, Wen-Lang, Yue, Mei, Kurti, Aishe, Shinohara, Mitsuru, Jansen-West, Karen, Perkerson, Emilie, Castanedes-Casey, Monica et al. · 2015 · Human Molecular Genetics
  46. Microglial priming and Alzheimer’s disease: a possible role for (early) immune challenges and epigenetics?
    Hoeijmakers, Lianne, Heinen, Yvonne, van Dam, Anne-Marie, Lucassen, Paul J., Korosi, Aniko · 2016 · Frontiers in Human Neuroscience
  47. Acute Sleep Deprivation Increases Serum Levels of Neuron-Specific Enolase (NSE) and S100 Calcium Binding Protein B (S-100B) in Healthy Young Men
    Benedict, Christian, Cedernaes, Jonathan, Giedraitis, Vilmantas, Nilsson, Emil K., Hogenkamp, Pleunie S., Vågesjö, Evelina, Massena, Sara, Pettersson, Ulrika, Christoffersson, Gustaf, Phillipson, Mia et al. · 2014 · Sleep
  48. Using Human iPSC-Derived Neurons to Model TAU Aggregation
    Verheyen, An, Diels, Annick, Dijkmans, Joyce, Oyelami, Tutu, Meneghello, Giulia, Mertens, Liesbeth, Versweyveld, Sofie, Borgers, Marianne, Buist, Arjan, Peeters, Pieter et al. · 2015 · PLOS ONE
  49. Obesity, Insulin Resistance, and Alzheimer's Disease
    Hildreth, Kerry L., Van Pelt, Rachael E., Schwartz, Robert S. · 2012 · Obesity
  50. Dendritic Spines: Mediators of Cognitive Resilience in Aging and Alzheimer’s Disease
    Walker, Courtney K., Herskowitz, Jeremy H. · 2021 · The Neuroscientist
  51. Beta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons
    Kelly, B.L., Ferreira, A. · 2007 · Neuroscience
  52. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD
    Starr, Alexander, Sattler, Rita · 2018 · Brain Research
  53. Aβ oligomers inhibit synapse remodelling necessary for memory consolidation
    Freir, Darragh B., Fedriani, Rocio, Scully, Darren, Smith, Imelda M., Selkoe, Dennis J., Walsh, Dominic M., Regan, Ciaran M. · 2011 · Neurobiology of Aging
  54. Effect of neuroinflammation on the progression of Alzheimer’s disease and its significant ramifications for novel anti-inflammatory treatments
    Kamila, Pritam, Kar, Koyel, Chowdhury, Sailee, Chakraborty, Priyanka, Dutta, Ria, S, Sowmiya, Singh S, Ankul, Prajapati, Bhupendra Gopalbhai · 2025 · IBRO Neuroscience Reports
  55. The role of PI3K signaling pathway in Alzheimer’s disease
    Pan, Jingying, Yao, Qi, Wang, Yankai, Chang, Suyan, Li, Chenlong, Wu, Yongjiang, Shen, Jianhong, Yang, Riyun · 2024 · Frontiers in Aging Neuroscience
  56. Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes
    Mosconi, Lisa, Berti, Valentina, Swerdlow, Russell H, Pupi, Alberto, Duara, Ranjan, de Leon, Mony · 2010 · Human Genomics
  57. Inflammasome activation under high cholesterol load triggers a protective microglial phenotype while promoting neuronal pyroptosis
    de Dios, Cristina, Abadin, Xenia, Roca-Agujetas, Vicente, Jimenez-Martinez, Marina, Morales, Albert, Trullas, Ramon, Mari, Montserrat, Colell, Anna · 2023 · Translational Neurodegeneration
  58. Quantitative electroencephalography as a marker of cognitive fluctuations in dementia with Lewy bodies and an aid to differential diagnosis
    Stylianou, Myrto, Murphy, Nicholas, Peraza, Luis R., Graziadio, Sara, Cromarty, Ruth, Killen, Alison, O' Brien, John T., Thomas, Alan J., LeBeau, Fiona E.N., Taylor, John-Paul · 2018 · Clinical Neurophysiology
  59. Spreading depression requires microglia and is decreased by their M2a polarization from environmental enrichment
    Pusic, Kae M., Pusic, Aya D., Kemme, Jordan, Kraig, Richard P. · 2014 · Glia
  60. Iron Deposition Leads to Hyperphosphorylation of Tau and Disruption of Insulin Signaling
    Wan, Wenbin, Cao, Lan, Kalionis, Bill, Murthi, Padma, Xia, Shijin, Guan, Yangtai · 2019 · Frontiers in Neurology
  61. Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases
    Ramos, Eliana Marisa, Dokuru, Deepika Reddy, Van Berlo, Victoria, Wojta, Kevin, Wang, Qing, Huang, Alden Y., Deverasetty, Sandeep, Qin, Yue, van Blitterswijk, Marka, Jackson, Jazmyne et al. · 2020 · Alzheimer's &amp; Dementia
  62. Physiological Roles of β-amyloid in Regulating Synaptic Function: Implications for AD Pathophysiology
    Cai, Wenwen, Li, Linxi, Sang, Shaoming, Pan, Xiaoli, Zhong, Chunjiu · 2023 · Neuroscience Bulletin
  63. Neuroprotective strategies in Alzheimer’s disease
    Longo, Frank M., Massa, Stephen M. · 2004 · NeuroRx
  64. NRBF2 is involved in the autophagic degradation process of APP-CTFs in Alzheimer disease models
    Yang, Chuanbin, Cai, Cui-Zan, Song, Ju-Xian, Tan, Jie-Qiong, Durairajan, Siva Sundara Kumar, Iyaswamy, Ashok, Wu, Ming-Yue, Chen, Lei-Lei, Yue, Zhenyu, Li, Min et al. · 2017 · Autophagy
  65. Metal-catalyzed oxidation of Aβ and the resulting reorganization of Cu binding sites promote ROS production
    Cheignon, Clémence, Faller, Peter, Testemale, Denis, Hureau, Christelle, Collin, Fabrice · 2016 · Metallomics
  66. Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer’s Disease
    Pérez, María José, Vergara-Pulgar, Katiana, Jara, Claudia, Cabezas-Opazo, Fabian, Quintanilla, Rodrigo A. · 2018 · Molecular Neurobiology
  67. Posttraumatic Stress Disorder-Like Induction Elevates β-Amyloid Levels, Which Directly Activates Corticotropin-Releasing Factor Neurons to Exacerbate Stress Responses
    Justice, Nicholas J., Huang, Longwen, Tian, Jin-Bin, Cole, Allysa, Pruski, Melissa, Hunt, Albert J., Flores, Rene, Zhu, Michael X., Arenkiel, Benjamin R., Zheng, Hui · 2015 · The Journal of Neuroscience
  68. <i>APOE</i> ε4 associates with microglial activation independently of Aβ plaques and tau tangles
    Ferrari-Souza, João Pedro, Lussier, Firoza Z., Leffa, Douglas T., Therriault, Joseph, Tissot, Cécile, Bellaver, Bruna, Ferreira, Pâmela C. L., Malpetti, Maura, Wang, Yi-Ting, Povala, Guilherme et al. · 2023 · Science Advances
  69. Phosphoinositides signaling modulates microglial actin remodeling and phagocytosis in Alzheimer’s disease
    Desale, Smita Eknath, Chinnathambi, Subashchandrabose · 2021 · Cell Communication and Signaling
  70. Tau reduction affects excitatory and inhibitory neurons differently, reduces excitation/inhibition ratios, and counteracts network hypersynchrony
    Chang, Che-Wei, Evans, Mark D., Yu, Xinxing, Yu, Gui-Qiu, Mucke, Lennart · 2021 · Cell Reports
  71. Alzheimer’s-like pathology in aging rhesus macaques: Unique opportunity to study the etiology and treatment of Alzheimer’s disease
    Arnsten, Amy F. T., Datta, Dibyadeep, Leslie, Shannon, Yang, Sheng-Tao, Wang, Min, Nairn, Angus C. · 2019 · Proceedings of the National Academy of Sciences
  72. Persistent repression of tau in the brain using engineered zinc finger protein transcription factors
    Wegmann, Susanne, DeVos, Sarah L., Zeitler, Bryan, Marlen, Kimberly, Bennett, Rachel E., Perez-Rando, Marta, MacKenzie, Danny, Yu, Qi, Commins, Caitlin, Bannon, Riley N. et al. · 2021 · Science Advances
  73. Activation of PAR-1 Kinase and Stimulation of Tau Phosphorylation by Diverse Signals Require the Tumor Suppressor Protein LKB1
    Wang, Ji-Wu, Imai, Yuzuru, Lu, Bingwei · 2007 · The Journal of Neuroscience
  74. mTOR and neuronal cell cycle reentry: how impaired brain insulin signaling promotes Alzheimer's disease
    Norambuena, Andrés, Wallrabe, Horst, McMahon, Lloyd, Silva, Antonia, Swanson, Eric, Khan, Shahzad S., Baerthlein, Daniel, Kodis, Erin, Oddo, Salvatore, Mandell, James W. et al. · 2017 · Alzheimer's &amp; Dementia
  75. Three-dimensional analysis of synapses in the transentorhinal cortex of Alzheimer’s disease patients
    Domínguez-Álvaro, M., Montero-Crespo, M., Blazquez-Llorca, L., Insausti, R., DeFelipe, J., Alonso-Nanclares, L. · 2018 · Acta Neuropathologica Communications
  76. BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr348 phosphorylation
    Sartori, Maxime, Mendes, Tiago, Desai, Shruti, Lasorsa, Alessia, Herledan, Adrien, Malmanche, Nicolas, Mäkinen, Petra, Marttinen, Mikael, Malki, Idir, Chapuis, Julien et al. · 2019 · Acta Neuropathologica
  77. Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer’s disease
    Zhang, Si, Zhao, Jiehao, Zhang, Yuhu, Zhang, Yun, Cai, Fang, Wang, Lijuan, Song, Weihong · 2019 · Alzheimer's Research &amp; Therapy
  78. Intake of niacin, folate, vitamin B-6, and vitamin B-12 through young adulthood and cognitive function in midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) study
    Qin, Bo, Xun, Pengcheng, Jacobs, David R, Zhu, Na, Daviglus, Martha L, Reis, Jared P, Steffen, Lyn M, Van Horn, Linda, Sidney, Stephen, He, Ka · 2017 · The American Journal of Clinical Nutrition
  79. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models
    Liao, Fan, Zhang, Tony J., Jiang, Hong, Lefton, Katheryn B., Robinson, Grace O., Vassar, Robert, Sullivan, Patrick M., Holtzman, David M. · 2015 · Acta Neuropathologica Communications
  80. Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer’s disease through inhibition of inflammation
    Malm, Tarja, Mariani, Monica, Donovan, Lauren J, Neilson, Lee, Landreth, Gary E · 2015 · Journal of Neuroinflammation
  81. Roles of eukaryotic elongation factor 2 kinase (eEF2K) in neuronal plasticity, cognition, and Alzheimer disease
    Ma, Tao · 2023 · Journal of Neurochemistry
  82. Tau Immunotherapies for Alzheimer’s Disease and Related Tauopathies: Progress and Potential Pitfalls1
    Sigurdsson, Einar M. · 2018 · Journal of Alzheimer s Disease
  83. Review: Disruption of the Postsynaptic Density in Alzheimer’s Disease and Other Neurodegenerative Dementias
    Yuesong Gong, Lippa, Carol F. · 2010 · American Journal of Alzheimer's Disease &amp; Other Dementias®
  84. Control of dendritic spine morphological and functional plasticity by small GTPases.
    Woolfrey, Kevin M., Srivastava, Deepak P. · 2016 · Neural Plasticity
  85. Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging
    Cerami, Chiara, Iaccarino, Leonardo, Perani, Daniela · 2017 · International Journal of Molecular Sciences
  86. Inhibiting amyloid-β cytotoxicity through its interaction with the cell surface receptor LilrB2 by structure-based design
    Cao, Qin, Shin, Woo Shik, Chan, Henry, Vuong, Celine K., Dubois, Bethany, Li, Binsen, Murray, Kevin A., Sawaya, Michael R., Feigon, Juli, Black, Douglas L. et al. · 2018 · Nature Chemistry
  87. ALS and frontotemporal dysfunction: a review
    Achi, Eugene Y., Rudnicki, Stacy A. · 2012 · Neurology Research International
  88. Trichostatin A ameliorates Alzheimer’s disease-related pathology and cognitive deficits by increasing albumin expression and Aβ clearance in APP/PS1 mice
    Su, Qiang, Li, Tian, He, Pei-Feng, Lu, Xue-Chun, Yu, Qi, Gao, Qi-Chao, Wang, Zhao-Jun, Wu, Mei-Na, Yang, Dan, Qi, Jin-Shun · 2021 · Alzheimer's Research &amp; Therapy
  89. Reduction of Detyrosinated Microtubules and Golgi Fragmentation Are Linked to Tau-Induced Degeneration in Astrocytes
    Yoshiyama, Yasumasa, Zhang, Bin, Bruce, Jennifer, Trojanowski, John Q., Lee, Virginia M.-Y. · 2003 · The Journal of Neuroscience
  90. Ca2+ Dyshomeostasis Disrupts Neuronal and Synaptic Function in Alzheimer’s Disease
    McDaid, John, Mustaly-Kalimi, Sarah, Stutzmann, Grace E. · 2020 · Cells
  91. Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration
    van Dijk, Gertjan, van Heijningen, Steffen, Reijne, Aaffien C., Nyakas, Csaba, van der Zee, Eddy A., Eisel, Ulrich L. M. · 2015 · Frontiers in Neuroscience
  92. Alzheimer's disease: An acquired neurodegenerative laminopathy
    Frost, Bess · 2016 · Nucleus
  93. Imaging Synaptic Density: The Next Holy Grail of Neuroscience?
    Serrano, Maria Elisa, Kim, Eugene, Petrinovic, Marija M., Turkheimer, Federico, Cash, Diana · 2022 · Frontiers in Neuroscience
  94. Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer's disease mutations but not by inhibition of BACE1
    Johnson, Erik C. B., Ho, Kaitlyn, Yu, Gui-Qiu, Das, Melanie, Sanchez, Pascal E., Djukic, Biljana, Lopez, Isabel, Yu, Xinxing, Gill, Michael, Zhang, Weiping et al. · 2020 · Molecular Neurodegeneration
  95. Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure
    Vorobyeva, Anna G., Saunders, Aleister J. · 2018 · Cilia
  96. Specific depletion of resident microglia in the early stage of stroke reduces cerebral ischemic damage
    Li, Ting, Zhao, Jin, Xie, Wenguang, Yuan, Wanru, Guo, Jing, Pang, Shengru, Gan, Wen-Biao, Gómez-Nicola, Diego, Zhang, Shengxiang · 2021 · Journal of Neuroinflammation
  97. Aducanumab—Hope or Disappointment for Alzheimer’s Disease
    Wojtunik-Kulesza, Karolina, Rudkowska, Monika, Orzeł-Sajdłowska, Anna · 2023 · International Journal of Molecular Sciences
  98. Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes
    Piccialli, Ilaria, Tedeschi, Valentina, Caputo, Lucia, D’Errico, Stefano, Ciccone, Roselia, De Feo, Vincenzo, Secondo, Agnese, Pannaccione, Anna · 2022 · Frontiers in Pharmacology
  99. Aβ42 neurotoxicity in primary co-cultures: effect of apoE isoform and Aβ conformation
    Manelli, Arlene M., Bulfinch, Lindsey C., Sullivan, Patrick M., LaDu, Mary Jo · 2007 · Neurobiology of Aging
  100. The Positive Side of the Alzheimer’s Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1
    Ciccone, Lidia, Shi, Chenghui, di Lorenzo, Davide, Van Baelen, Anne-Cécile, Tonali, Nicolo · 2020 · Molecules